It has been established that NCAPG2 overexpression could potentially alter the signaling pathways, like STAT3 and NF-κB, or other oncogenes to promote proliferation and invasion of the malignancy cells in various cancers including liver cancer, melanoma, lung cancer and glioma (12, 15–17). This evidence concerns the gene NCAPG2 and central nervous system cancer.